Seeking people aged 1-21 years old with certain kinds of solid tumor cancer for a study of an investigational drug.
Participants in this study will take the investigational drug tipifarnib during 28-day cycles for a period of up to 2 years.
What we're hoping for
We are studying an investigational drug called tipifarnib to reduce certain kinds of tumors in children aged 1 to 21 years old whose cancer has returned or gotten worse after treatment.
ClinicalTrials.gov Identifier: NCT04284774